Novel Mechanisms of Action of the Biologicals in Rheumatic Diseases
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Mechanisms of Action of the Biologicals in Rheumatic Diseases
Authors
Keywords
Rheumatoid arthritis, Biological agents, Immunogenicity, Biosimilarity
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume 47, Issue 1, Pages 6-16
Publisher
Springer Nature
Online
2013-01-23
DOI
10.1007/s12016-013-8359-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5
- (2012) Paolo Macor et al. ARTHRITIS AND RHEUMATISM
- Can we reduce the dosage of biologics in spondyloarthritis?
- (2012) Ignazio Olivieri et al. AUTOIMMUNITY REVIEWS
- The role of Fc receptors and complement in autoimmunity
- (2012) Sidonia Mihai et al. AUTOIMMUNITY REVIEWS
- Different effects of biological drugs in rheumatoid arthritis
- (2012) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Immunogenicity and autoimmunity during anti-TNF therapy
- (2012) F. Atzeni et al. AUTOIMMUNITY REVIEWS
- To B or Not to B the Conductor of Rheumatoid Arthritis Orchestra
- (2012) Rita A. Moura et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics
- (2012) Gerdien Mijnheer et al. CURRENT OPINION IN RHEUMATOLOGY
- Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases
- (2012) Kaisa E. Happonen et al. IMMUNOBIOLOGY
- Multiple Courses of Rituximab Produce Sustained Clinical and Radiographic Efficacy and Safety in Patients with Rheumatoid Arthritis and an Inadequate Response to 1 or More Tumor Necrosis Factor Inhibitors: 5-Year Data from the REFLEX Study
- (2012) E. C. KEYSTONE et al. JOURNAL OF RHEUMATOLOGY
- Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis
- (2012) E. Choy RHEUMATOLOGY
- Crosstalk between reverse cholesterol transport and innate immunity
- (2012) Kathleen M. Azzam et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?
- (2011) Klaus Bendtzen ARTHRITIS AND RHEUMATISM
- Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature
- (2011) Francesca Ingegnoli et al. AUTOIMMUNITY REVIEWS
- Switching rheumatoid arthritis treatments: An update
- (2011) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors
- (2011) Eleonora Ballanti et al. AUTOIMMUNITY REVIEWS
- An overview on the genetic of rheumatoid arthritis: A never-ending story
- (2011) Carlo Perricone et al. AUTOIMMUNITY REVIEWS
- Anti-TNF therapy: Safety aspects of taking the risk
- (2011) Hemda Rosenblum et al. AUTOIMMUNITY REVIEWS
- Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists
- (2011) Christophe Lallemand et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Unresolved issues in biologic therapy for rheumatoid arthritis
- (2011) Ronald F. van Vollenhoven Nature Reviews Rheumatology
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study
- (2010) E. Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis
- (2010) James P. Brodeur et al. ARTHRITIS AND RHEUMATISM
- All you wanted to know about anti-CCP but were afraid to ask
- (2010) Allan S. Wiik et al. AUTOIMMUNITY REVIEWS
- The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
- (2010) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Cardiac involvement in systemic rheumatic diseases: An update
- (2010) Piercarlo Sarzi-Puttini et al. AUTOIMMUNITY REVIEWS
- Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?
- (2010) Maurizio Benucci et al. AUTOIMMUNITY REVIEWS
- How early is the atherosclerotic risk in rheumatoid arthritis?
- (2010) Elena Bartoloni et al. AUTOIMMUNITY REVIEWS
- From endothelial dysfunction to atherosclerosis
- (2010) S. Sitia et al. AUTOIMMUNITY REVIEWS
- Adipocyte Modulation of High-Density Lipoprotein Cholesterol
- (2010) YuZhen Zhang et al. CIRCULATION
- Essential Role of Complement Mannose-Binding Lectin-Associated Serine Proteases-1/3 in the Murine Collagen Antibody-Induced Model of Inflammatory Arthritis
- (2010) N. K. Banda et al. JOURNAL OF IMMUNOLOGY
- Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis
- (2010) Alper M. van Sijl et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: Two faces of the same coin
- (2010) Elena Bartoloni et al. ARTHRITIS CARE & RESEARCH
- The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases
- (2009) F. A. S. Kurreeman et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
- (2009) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
- (2009) Mike J. L. Peters et al. ARTHRITIS AND RHEUMATISM
- Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways
- (2009) L. A. Trouw et al. ARTHRITIS AND RHEUMATISM
- Cardiovascular risk in rheumatoid arthritis
- (2009) Michael T. Nurmohamed AUTOIMMUNITY REVIEWS
- Predicting response to anti-TNF treatment in rheumatoid arthritis patients
- (2009) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis
- (2009) Péter Szodoray et al. AUTOIMMUNITY REVIEWS
- Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases
- (2009) Nádia Emi Aikawa et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Bronchospasm associated with anti-TNF treatment
- (2009) S. Dubey et al. CLINICAL RHEUMATOLOGY
- Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
- (2009) Natalia Wegner et al. IMMUNOLOGICAL REVIEWS
- The complement system in systemic autoimmune disease
- (2009) Min Chen et al. JOURNAL OF AUTOIMMUNITY
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies
- (2009) Klaus Bendtzen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
- (2009) Suad Hannawi et al. ARTHRITIS RESEARCH & THERAPY
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
- (2008) T R D J Radstake et al. ANNALS OF THE RHEUMATIC DISEASES
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
- (2008) Hiroki Mitoma et al. ARTHRITIS AND RHEUMATISM
- Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
- (2008) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Influence of reverse signaling via membrane TNF-α on cytotoxicity of NK92 cells
- (2008) Mingxia Yu et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Clinical immunotoxicity of therapeutic proteins
- (2008) Jacques Descotes et al. Expert Opinion on Drug Metabolism & Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now